Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diabetes self-care poor in Scotland

This article was originally published in Clinica

Executive Summary

Most diabetics inadequately monitor their own blood glucose levels, according to a study of 800 Scottish diabetics. It found that less than 20% of subjects tested their blood glucose levels daily. Many did no tests at all (British Medical Journal, vol 319, July 10, pp83-86). The researchers found a close relationship between testing frequency and improved control of blood sugar levels. They estimate the annual cost of self-testing four times a day at £409 ($600) - much lower than the cost of treating diabetic complications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT078862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel